<DOC>
	<DOCNO>NCT02242214</DOCNO>
	<brief_summary>The design study post-marketing , observational , multi-centre open-label . The study provide treatment ; patient misoprostol 200 µg vaginal delivery system ( VDS ) prescribe may include . All direction medication usage patient monitoring solely discretion investigator accordance usual practice must consistent Dutch prescribe information misoprostol 200 µg VDS . No ( invasive ) study-related intervention measurement do , procedure routinely perform induction labour . No effort expect study subject . 150 patient 20 Dutch centre include .</brief_summary>
	<brief_title>REgistry MisOprostol 200 µg Vaginal dElivery System</brief_title>
	<detailed_description />
	<mesh_term>Misoprostol</mesh_term>
	<criteria>Diagnosis induction labour woman unfavourable cervix , 36 week gestation , induction clinically indicate Decision make prescribe misoprostol 200 µg VDS accord Summary Product Characteristics ( SmPC ) Willingness ability provide write informed consent Misoprostol 200 µg VDS contraindicate accord SmPC</criteria>
	<gender>Female</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2015</verification_date>
</DOC>